Huang SM - Search Results

1

Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation.

Zhao P, Vieira Mde L, Grillo JA, Song P, Wu TC, Zheng JH, Arya V, Berglund EG, Atkinson AJ Jr, Sugiyama Y, Pang KS, Reynolds KS, Abernethy DR, Zhang L, Lesko LJ, Huang SM. Zhao P, et al. Among authors: huang sm. J Clin Pharmacol. 2012 Jan;52(1 Suppl):91S-108S. doi: 10.1177/0091270011415528. J Clin Pharmacol. 2012. PMID: 22232759

2

Population pharmacokinetics. A regulatory perspective.

Sun H, Fadiran EO, Jones CD, Lesko L, Huang SM, Higgins K, Hu C, Machado S, Maldonado S, Williams R, Hossain M, Ette EI. Sun H, et al. Among authors: huang sm. Clin Pharmacokinet. 1999 Jul;37(1):41-58. doi: 10.2165/00003088-199937010-00003. Clin Pharmacokinet. 1999. PMID: 10451782 Review.

3

FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling.

Davit B, Reynolds K, Yuan R, Ajayi F, Conner D, Fadiran E, Gillespie B, Sahajwalla C, Huang SM, Lesko LJ. Davit B, et al. Among authors: huang sm. J Clin Pharmacol. 1999 Sep;39(9):899-910. doi: 10.1177/00912709922008515. J Clin Pharmacol. 1999. PMID: 10471980

4

Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions: study design and data analysis issues.

Huang SM, Lesko LJ, Williams RL. Huang SM, et al. J Clin Pharmacol. 1999 Oct;39(10):1006-14. doi: 10.1177/00912709922011764. J Clin Pharmacol. 1999. PMID: 10516934

5

Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives.

Ibrahim S, Honig P, Huang SM, Gillespie W, Lesko LJ, Williams RL. Ibrahim S, et al. Among authors: huang sm. J Clin Pharmacol. 2000 Jan;40(1):31-8. doi: 10.1177/00912700022008658. J Clin Pharmacol. 2000. PMID: 10631619 Review.

6

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.

Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD. Wang Z, et al. Among authors: huang sm. Clin Pharmacol Ther. 2001 Oct;70(4):317-26. Clin Pharmacol Ther. 2001. PMID: 11673747 Clinical Trial.

7

Effect of St John's wort on the pharmacokinetics of fexofenadine.

Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD. Wang Z, et al. Among authors: huang sm. Clin Pharmacol Ther. 2002 Jun;71(6):414-20. doi: 10.1067/mcp.2002.124080. Clin Pharmacol Ther. 2002. PMID: 12087344 Clinical Trial.

8

Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions.

Yuan R, Madani S, Wei XX, Reynolds K, Huang SM. Yuan R, et al. Among authors: huang sm. Drug Metab Dispos. 2002 Dec;30(12):1311-9. doi: 10.1124/dmd.30.12.1311. Drug Metab Dispos. 2002. PMID: 12433797

9

Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop.

Lesko LJ, Salerno RA, Spear BB, Anderson DC, Anderson T, Brazell C, Collins J, Dorner A, Essayan D, Gomez-Mancilla B, Hackett J, Huang SM, Ide S, Killinger J, Leighton J, Mansfield E, Meyer R, Ryan SG, Schmith V, Shaw P, Sistare F, Watson M, Worobec A. Lesko LJ, et al. Among authors: huang sm. J Clin Pharmacol. 2003 Apr;43(4):342-58. doi: 10.1177/0091270003252244. J Clin Pharmacol. 2003. PMID: 12723455

10

Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?

Huang SM, Lesko LJ. Huang SM, et al. J Clin Pharmacol. 2004 Jun;44(6):559-69. doi: 10.1177/0091270004265367. J Clin Pharmacol. 2004. PMID: 15145962 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,277 results

Search Page

Filters